Skip to main content

Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

CDK4/6 Inhibitors

Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

CDK4/6 Inhibitors

A Pharmacist’s Perspective on CDK4/6 Inhibitors

Robert C. Wolf, PharmD

CDK4/6 Inhibitors

A Payer’s Perspective on CDK4/6 Inhibitors

Kenneth L. Schaecher, MD, FACP, CPC

CDK4/6 Inhibitors

A Nurse Navigator’s Perspective on CDK4/6 Inhibitors

Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

Results 1 - 4 of 4